e.g. Tata motors, Reliance MF, 500570

Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Download announcement < Back
27 Nov 2025
Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.
View all announcements for Zydus Lifesciences Ltd Source: BSE India

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback